Referencing: footnoting, AGLC

Bibliography: compulsory

Please read:

- GATT Articles 1(1) and 3 (Essential Materials, pp 8-10) https://treaties.un.org/doc/Publication/UNTS/Volume%2055/volume-55-I-814-English.pdf

https://d3cgwrxphz0fqu.cloudfront.net/7f/45/7f45c4940a4861b1b6bc2cb847a19b2bfdde42cd?response-content-disposition=inline%3Bfilename%3D%22gatt1994_art1_gatt47.pdf%22&response-content-type=application%2Fpdf&Expires=1652535360&Signature=U0yCU~x-t0uHqER16YVTjczGZcWVV2nIJCTul4zbNRy5lX6f3bsVaCIup1NMJqtF8YDeT~57dErkJWJ4QkekRa1dxhdA~ZMUpvPsSiPDuijqa9CPIUBmDbglyG7QmqM95XhCQP47p9vGeNf3o8rEo3EwHCQnMA8bqxYIBCFWBsSE7fKXqqnT3IZ3oPoxA~i791W4VNI-kYanizMbZDLsrA3mP7NluFuPYYSA8fPUxPRG8DT6Rai2dVuaACOTrgxYgXwn4-oZfy6wUjd7j1kONIe4yPPFQ6vxhI9I5EgCPbnO3SmA6zJOKazl950fttUIaeEL4j9Rt9BlwpcJPoq9PA__&Key-Pair-Id=APKAJRIEZFHR4FGFTJHA

- 'Settling a Dispute: European Communities: Measures Affecting the Approval and Marketing of Biotech Products' (Essential Materials, pp 21-26)

https://d3cgwrxphz0fqu.cloudfront.net/2b/c0/2bc072e23c6d4cb9c7d954a6c2a2f44df2edfac5?response-content-disposition=inline%3Bfilename%3D%22A%20Section%201%20WTO%20w%20pp%20%281%29-%20gatt%20agt.pdf%22&response-content-type=application%2Fpdf&Expires=1652535480&Signature=UNsFHoPiBGPZPu7WBwCVjdTtyw00GKON4c0T8-mJI7NPeG~uKoe3u3f~S4Uj27~LMLdR5NrJT9SQC9NHQnTPrLrQSXnRiREN4tkJnNSXkYsS-cEt-zU-uG90gZTwZie1A3IkhlKuYVD8N6SGvsvD1Z6t27PBgEFEGjsInkbHiSVKN3lZ~QNUVOtiEzX5vP~iuj05gI5IIxY9P2KE5hrS8BQJoQkD1gAVBo5zSua5WIgQLtcNimdWxN5MsVfWt8Igx~0yyzB3lQVipYdkaExN6JaRxXaFeQgwa6IiBB1lj6lf2alpjIsaBR8llxoxCFfYU-0zlv6duCyjubCbXhMjKg__&Key-Pair-Id=APKAJRIEZFHR4FGFTJHA

and answer the following questions:

1. Explain the concept of a 'like product' with reference to GATT Articles 1(1) and 3, and caselaw.

2. Why is the concept of 'like product' included in the General Agreement on Tariffs and Trade (GATT)?